Mutagenicity of nitrosourea compounds for Salmonella typhimurium.
The nitrosourea derivatives 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037), 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Me-CCNU; NSC-95441), and 1-methyl-1-nitrosourea (MNU; NSC-23909) were screened for mutagenic potential with Salmonella typhimurium strains G46 and TA1530 in vitro and in vivo. Alu were also mutagenic in the host-mediated assay. Four additional chemotherapeutic nitrosoureas were tested in vitro, three of which were mutagenic. The lack of activity of the fourth agent was probably a reflection of its stability in solution rather than a true indication of mutagenic potential. All eight agents were tested in a repair test with S. typhimurium strains TA1978 and TA1538. Results of this test were negative, reflecting the insensitivity of these strains to ethylating and methylating agents. The insensitivity of the host-mediated assay is also discussed.
D002330:Carmustine / Q000494:pharmacology; D008130:Lomustine / Q000494:pharmacology; D008722:Methods; D008770:Methylnitrosourea / Q000494:pharmacology; D009153:Mutagens; D009607:Nitrosourea Compounds / Q000494:pharmacology*; D012486:Salmonella typhimurium / Q000187:drug effects*; D012673:Semustine / Q000494:pharmacology
D009153:Mutagens; D009607:Nitrosourea Compounds; D012673:Semustine; D008770:Methylnitrosourea; D008130:Lomustine; D002330:Carmustine